Dave Denton, chief financial officer of Pfizer Inc., center left, and Albert Bourla, chief executive officer of Pfizer Inc., center, ring the closing bell on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March 4, 2026.
Michael Nagle | Bloomberg | Getty Images
Pfizer said on Thursday that finance chief Dave Denton will step down and leave the company on August 15 to take a role in the consumer goods industry.
The U.S. drugmaker named Cecile Guegan, senior vice president of finance for its global biopharmaceutical business, as interim CFO, effective August 16.
Pfizer said it will conduct an internal and external search for a permanent successor. Denton and Guegan will work together on the transition, the company said.